Technical Analysis for OLMA - Olema Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 6.25 -5.73% -0.38
OLMA closed down 5.73 percent on Thursday, February 6, 2025, on 44 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion -5.73%
Upper Bollinger Band Touch Strength -5.73%
Stochastic Sell Signal Bearish 4.87%
NR7 Range Contraction 4.87%
Overbought Stochastic Strength 4.87%
Gapped Down Weakness 4.87%
Bearish Engulfing Bearish 2.29%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 10 hours ago
Possible Inside Day about 10 hours ago
60 Minute Opening Range Breakdown about 13 hours ago
Down 3% about 13 hours ago
Down 2 % about 14 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Olema Oncology is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers. Olema’s lead product candidate, OP-1250, is an orally available small molecule with combined activity as both a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD). It is currently being evaluated as a single agent in an ongoing Phase 1/2 clinical trial in patients with recurrent, locally advanced or metastatic ER-positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer. Olema is headquartered in San Francisco.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Breast Cancer Treatment Of Breast Cancer Epidermal Growth Factor Receptor Hormones Targeted Therapy Her2 Her2/Neu Estrogen Antiestrogens Estrogen Receptor Selective Estrogen Receptor Degraders

Is OLMA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Comments

Indicators

Indicator Value
52 Week High 16.775
52 Week Low 4.6
Average Volume 1,186,483
200-Day Moving Average 10.58
50-Day Moving Average 6.89
20-Day Moving Average 5.80
10-Day Moving Average 6.18
Average True Range 0.52
RSI (14) 50.50
ADX 18.28
+DI 23.33
-DI 16.15
Chandelier Exit (Long, 3 ATRs) 5.15
Chandelier Exit (Short, 3 ATRs) 6.15
Upper Bollinger Bands 6.72
Lower Bollinger Band 4.88
Percent B (%b) 0.74
BandWidth 31.63
MACD Line -0.09
MACD Signal Line -0.26
MACD Histogram 0.1711
Fundamentals Value
Market Cap 464.02 Million
Num Shares 74.2 Million
EPS -2.44
Price-to-Earnings (P/E) Ratio -2.56
Price-to-Sales 0.00
Price-to-Book 1.97
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.85
Resistance 3 (R3) 6.91 6.77 6.75
Resistance 2 (R2) 6.77 6.62 6.74 6.72
Resistance 1 (R1) 6.51 6.52 6.44 6.45 6.68
Pivot Point 6.37 6.37 6.34 6.34 6.37
Support 1 (S1) 6.11 6.22 6.04 6.05 5.82
Support 2 (S2) 5.97 6.12 5.94 5.78
Support 3 (S3) 5.71 5.97 5.75
Support 4 (S4) 5.65